Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis
Keywords:
Leishmaniasis
Drug repurposing
Antimicrobial peptides (AMPs)
Peptide 19-2.5
Peptide 19-4LF
Drug resistance
Proliferation
Cytokines
Note:
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Citation:
El-Dirany, R.; Fernández-Rubio, C. (Celia); Peña-Guerrero, J.; et al. "Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis". Pharmaceutics. 24 (11), 2022, 2528
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.